Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Paulfrobbins
    Junior Member
    • Mar 2015
    • 2

    #1

    Nextseq 500 base calling

    Does anyone have any suggestions about how to filter out the mis-called variants on Nextseq? Also, has anyone used the v2 kits? Is the fidelity significantly improved?
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    We are about to run a test on the NextSeq v2 chemistry, so I'll probably have some data in a week or two.

    Comment

    • Paulfrobbins
      Junior Member
      • Mar 2015
      • 2

      #3
      Thank you. We are anxious to see if we can improve the reliability of our Nextseq data. Our group at the National Cancer Institute is attempting to identify mutated gene products expressed in cancer cells that can be recognized by patient immune cells that will allow us to develop effective cancer therapies. We purchased a Nextseq because we needed to get our data quickly in order to develop treatments for patients with advanced cancer, and we have already identified many targets using this approach. Enhancing the accuracy of the variant calls would make this process simpler, as it would help to eliminate many of the false positives. Some of these are easy to identify as they appear in repeated tumor samples - I presume these are regions of the genome that are difficult to sequence. We also merge whole exome with RNAseq, which helps to validate the calls.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      28 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...